Abonnement à la biblothèque: Guest
Critical Reviews™ in Oncogenesis

Publication de 4  numéros par an

ISSN Imprimer: 0893-9675

ISSN En ligne: 2162-6448

SJR: 0.395 SNIP: 0.322 CiteScore™:: 2.5 H-Index: 54

Indexed in

Current Status of Radiation Therapy for the Management of Rectal Cancer

Volume 17, Numéro 4, 2012, pp. 331-343
DOI: 10.1615/CritRevOncog.v17.i4.30
Get accessGet access

RÉSUMÉ

Neoadjuvant chemoradiation for stage II and III rectal adenocarcinoma patients is delivered on a routine basis. This treatment paradigm, built on decades of clinical study, is continuously evolving. While multiple radiosensitizers have gained a great deal of interest over the past couple of decades, 5-fluorouracil still remains as the standard radiosensitizing agent. Long-course preoperative chemoradiotherapy is the current standard of care in the Unites States, but short-course hypofractionated preoperative radiotherapy is advocated by some investigators. This review will discuss the current standard of care in the preoperative setting for patients with rectal cancer and will also examine the novel ways in which investigators are modifying this regimen in an effort to improve patient outcomes.

CITÉ PAR
  1. Peng Yi-Fan, Tumor regression grades: Potential outcome predictor of locally advanced rectal adenocarcinoma after preoperative radiotherapy, World Journal of Gastroenterology, 21, 6, 2015. Crossref

  2. Wu Xiao-Yu, Wu Zhen-Feng, Cao Qin-Hong, Chen Che, Chen Zhi-Wei, Xu Zhe, Li Wei-Su, Liu Fu-Kun, Yao Xue-Quan, Li Gang, Insulin-like growth factor receptor-1 overexpression is associated with poor response of rectal cancers to radiotherapy, World Journal of Gastroenterology, 20, 43, 2014. Crossref

  3. Chen Junqi, Ning Chengyun, Zhou Zhengnan, Yu Peng, Zhu Ye, Tan Guoxin, Mao Chuanbin, Nanomaterials as photothermal therapeutic agents, Progress in Materials Science, 99, 2019. Crossref

  4. Nasrolahi Hamid, Mirzaei Sepideh, Mohammadianpanah Mohammad, Bananzadeh Ali Mohammad, Mokhtari Maral, Sasani Mohammad Reza, Mosalaei Ahmad, Omidvari Shapour, Ansari Mansour, Ahmadloo Niloofar, Hamedi Seyed Hasan, Khanjani Nezhat, Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial, Annals of Coloproctology, 35, 5, 2019. Crossref

  5. Hosseini Sare, Nguyen NamPhong, Mohammadianpanah Mohammad, Mirzaei Sepideh, Bananzadeh Ali Mohammad, Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study, Journal of Gastrointestinal Cancer, 50, 4, 2019. Crossref

Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections Prix et politiques d'abonnement Begell House Contactez-nous Language English 中文 Русский Português German French Spain